Absci
Absci is a biotechnology company specializing in drug discovery and development using artificial intelligence. They focus on creating biologics for various diseases, partnering with pharmaceutical companies to accelerate the development of innovative therapies. Their Integrated Drug Creation platform allows for rapid design and optimization of biologics, addressing the challenges of traditional drug development processes.
Headcount
Website visitors
Workforce
Headcount by location
- United States96%
- Serbia4.4%
Split by department
- Engineering & R&D52%
- Healthcare15%
- Finance & Administration7.7%
- Founder, Owner & Executive3.2%
- Other23%
Seniority distribution
- Less than 5 years64%
- 5 to 10 years30%
- 10 to 20 years3.4%
- 20 to 30 years1.3%
- 30 years and more0.7%
Funding
Raised to date
- 24 Jun 2026Series Other$100.0MAdage Capital Management, Bvf Partners, L.P, Columbia Threadneedle Investments, Invus, Eli Lilly and Company, Redmile Group
- 18 Aug 2025Ipo$50.0MCasdin Capital, Redmile Group
9 earlier rounds, with their terms and sources.
Investors
Gates FoundationBill & Melinda Gates Foundation is a not‑for‑profit private foundation headquartered in Seattle, US. It provides grant funding, research support, and partnership programs in global health, development, and education to governments, NGOs, research1,513United States
Eli Lilly and CompanyEli Lilly and Company is a global pharmaceutical and biotechnology leader headquartered in Indianapolis, US. It discovers, develops, manufactures, and markets prescription medicines across cardiometabolic, obesity, oncology, immunology and309United States
InvusInvus is an investment management firm that empowers entrepreneurs by providing capital and strategic advisory services. With over $10 billion under management, Invus partners with businesses to help them innovate and transform their industries201United States
Casdin CapitalCasdin Capital is an investment firm specializing in the life sciences sector. The company focuses on venture capital and investment management, partnering with businesses in healthcare, biotechnology, and technology to drive innovation and growth.132United States
Portfolio
Countries
- United States100%
Deal stage
- Company Acquisition100%
Deal size
- Unknown100%
Company size
- Unknown100%
Revenue
EBITDA
Revenue source: Public reported FY2025 (Stock exchange)
Recent news
Portfolio companies
Every holding by name, with what was paid, when, and how each one has grown since
People
How the team has changed month by month — joiners, leavers and where the hiring is going
Connections
Who at your firm already knows someone here, and how warm the path is
The full Absci profile lives in Inven.
Your competitors are already on Inven
See how Inven turns hours of manual research into a single, structured workflow.